We demonstrated that the combination use of leflunomide and benazepril could improve the renal function and reduce the renal injury of DN rats through reducing the levels of NF-κb, TGF-β and TRPC6 and inhibiting cell apoptosis of high-glucose induced glomerular mesangial cells. The gene discussed is NFKB1; the disease is liver dysplastic nodule.